Key facts
- This page summarizes Joe W. Ferguson's Form 4 filing for TREACE MEDICAL CONCEPTS, INC. (TMCI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Oct 2021, 16:04.
Joe W. Ferguson - 06 Oct 2021 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)
- Reporting relationship
- SVP, Research & Development
- Issuer ticker
- TMCI
- Reported as of
- 06 Oct 2021
- Net transaction value
- +$30,864
- Reporting owner signature
- /s/ Jaime A. Frias as Attorney-in-fact for Joe W. Ferguson
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Joe W. Ferguson filed Form 4 for TREACE MEDICAL CONCEPTS, INC. (TMCI) on 08 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$30,864.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMCI
transaction
Common Stock
Options Exercise
- Transaction value
- $30,864
- Shares
- +308,641
- Change %
- +278%
- Price
- $0.1000*
- Shares after
- 419,756
- Date
- 06 Oct 2021
- Ownership
- Direct
TMCI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 85,575
- Date
- 06 Oct 2021
- Ownership
- Pensco Trust Company FBO Joe William Ferguson
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMCI
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -308,641
- Change %
- -55%
- Price
- $0.000000
- Shares after
- 248,994
- Date
- 06 Oct 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 308,641
- Exercise price
- $0.1000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option is fully vested and exercisable.